Monitor for any future conversion of this 13G to a 13D, which would signal activist intent. For now, the filing is routine and does not change the fundamental outlook for LXEO.
Price Chart
Executive Summary
JPMorgan Chase & Co. disclosed a 5.5% passive stake in Lexeo Therapeutics via a Schedule 13G filed October 13, 2026, holding 4,573,701 shares of common stock. This is a new passive filing by a large financial institution, indicating routine portfolio exposure rather than activist intent.
Key Financial Metrics
Key Facts
- JPMorgan Chase & Co. filed a Schedule 13G disclosing beneficial ownership of 4,573,701 shares of Lexeo Therapeutics common stock.
- The stake represents 5.5% of shares outstanding as of September 30, 2026.
- The filing is made under Rule 13d-1(b), confirming passive intent with no control or influence purpose.
- JPMorgan Chase Bank, N.A. and J.P. Morgan Investment Management Inc. are listed as other reporting persons.
Financial Impact
Passive 5.5% stake — no direct financial impact from the filing itself.
Risk Factors
- JPMorgan could reduce or exit the position in future quarters without further disclosure until below 5%.
- No indication of engagement or catalyst from this passive holder.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000019617-26-000349 |
| Document: 0000019617-26-000349-index.html | 0000019617-26-000349 |
| Document: 0000019617-26-000349.txt | 0000019617-26-000349 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | SC 13G | $2.74 $3.02 | ▲ +10.22% | ▲ +11.37% | $2.92 (+6.57%) |
Sep 22, 2026 5w ago | 8-K | $4.07 $3.42 | ▼ −15.97% | ▼ −14.78% | $2.92 (−28.26%) |
Aug 12, 2026 10w ago | 8-K | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | $2.92 (−40.04%) |
Aug 12, 2026 10w ago | Press Release | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | $2.92 (−40.04%) |
Jul 1, 2026 16w ago | Insider Cluster | $4.69 $5.05 | ▲ +7.68% | ▲ +6.75% | $2.92 (−37.74%) |
Jun 17, 2026 18w ago | Press Release | $4.93 $4.70 | ▼ −4.67% | ▼ −3.00% | $2.92 (−40.77%) |
Jun 15, 2026 19w ago | 8-K | $4.65 $5.04 | ▲ +8.39% | ▲ +9.77% | $2.92 (−37.20%) |
Jun 12, 2026 19w ago | Institutional Cluster | $4.37 $4.93 | ▲ +12.81% | ▲ +12.14% | $2.92 (−33.18%) |
May 20, 2026 22w ago | Insider Cluster | $5.23 $5.14 | ▼ −1.72% | ▼ −3.57% | $2.92 (−44.17%) |
May 11, 2026 24w ago | 8-K | $6.12 $4.71 | ▼ −23.04% | ▼ −22.95% | $2.92 (−52.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers